Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that an Earnings Conference Call for the Quarter & Financial Year ended March 31, 2023, is scheduled to be held on Monday, May 29, 2023 at 5:00 P.M. (IST), hosted by Motilal Oswal. The details of earning call is enclosed herewith and is also available on the website of the Company at https://www.medanta.org/investor-relation/ Kindly take the above on record.
25-05-2023
Bigul

Global Health Ltd - 543654 - Board Meeting Intimation for Intimation For Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the Quarter and Financial Year ended 31st March, 2023. Further, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code for prevention of Insider Trading, the Trading Window of the Company is already closed from 1st April, 2023 and will re-open after 48 hours from the declaration of above said results.
19-05-2023
Bigul

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Dear Sir, Pursuant to Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41(2) of SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018, please find enclosed herewith the Monitoring Agency Report, towards utilization of proceeds of Initial Public Offer of the Company for the quarter ended March 31, 2023, issued by CRISIL Ratings Limited. You are requested to take the above information on your record.
11-05-2023
Bigul

Global Health Ltd - 543654 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

 Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyGlobal Health Ltd 2CIN NO.L85110DL2004PLC128319 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 100.28 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Rahul Ranjan Designation: Compliance Officer EmailId: rahul.ranjan@medanta.org Name of the Chief Financial Officer: Sanjeev Kumar Designation: Group Chief Financial Officer EmailId: sanjeev.saxena@medanta.org Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
27-04-2023
Bigul

Global Health Ltd - 543654 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Dear Sir, Pursuant to the Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1//27/2019 dated February 8, 2019, please find enclosed herewith the Annual Secretarial Compliance Report, for the Financial Year 2022-23, issued by M/s VAPN & Associates, Practicing Company Secretaries. This is for your information and record.
26-04-2023
Bigul

Global Health Ltd - 543654 - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Dear Sir, Please find enclosed herewith Certificate for the period from November 16, 2022 (i.e. the date of listing of Equity Shares of the Company) to March 31, 2023, received from Practicing Company Secretary, i.e. M/s Mukesh Agarwal & Co; in respect of compliance under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is for your information and record.
15-04-2023
Bigul

Global Health Ltd - 543654 - Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023

 Dear Sir, Please find enclosed herewith Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2023, duly signed by the Compliance Officer of the Company and Authorized Representative of Kfin Technologies Limited, the Registrar and Share Transfer Agent of the Company. This is for your information and record.
10-04-2023
Bigul

Global Health Ltd - 543654 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir, Please find enclosed herewith Certificate dated April 6, 2023, received from the Registrar and Transfer Agent of the Company i.e. Kfin Technologies Limited, w.r.t. compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the Quarter ended March 31, 2023. This is for your information and record.
10-04-2023
Bigul

Global Health Ltd - 543654 - Closure of Trading Window

 Dear Sir, This is to inform you that as per SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s Code for prevention of Insider Trading, the Trading Window for purchasing/selling or dealing in the Shares of the Company shall remain closed from Saturday, 1st April, 2023 and will open after 48 hours from the declaration of Financial Results of the Company, for the Quarter and Financial Year ending March 31, 2023. You are requested to take the above on record.
31-03-2023
Bigul

Global Health Ltd - 543654 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations)

 This is with reference to the letter Ref. No.- GHL/2022-23/EXCH/022 dated 13th February, 2023, wherein the Board of Directors of the Company has approved the binding Term Sheet for a new hospital at Indore on Operation & Management basis. In this regard, the Board of Directors of the Company at its Board Meeting held today i.e. Monday, 27th March, 2023, has extended the validity of Term Sheet till June 23, 2023 (earlier 60 days from date of execution) to execute necessary agreement subject to completion of due diligence. The Company has appointed a law firm, JSA advocates & solicitors, for the purposes of conducting the said due diligence and the same is underway. There are no changes in the disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on February 13, 2023 except above.
27-03-2023
Next Page
Close

Let's Open Free Demat Account